why choose us

First received: August 15, 2022

Clinical Trial: Cardiovascular Diagnostic in Assessment of Risk HDS and HCT in Patients With Haemoblasts.

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Cardiotoxicity

Study Type: INTERVENTIONAL


Official Title: Cardiovascular Diagnostic in Assessment of Risk High Dose Chemotherapy and Hematopoietic Cell Transplantation in Patients With Haemoblasts.

Brief Summary: In this research we investigate cardiological instrumental diagnostic, such as electrocardiography, echocardiography with the determination of global longitudinal strain, cardiopulmonary exercise test, and diagnostic of endothelial function by Angioscan for the prediction of cardiovascular complications after high dose chemotherapy and hematopoietic cell transplantation in patients with haemoblasts.

Read more